A recent study reveals that people who stop using new weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end conventional diet and exercise regimens.
Research printed in a major medical journal shows that while overweight individuals frequently drop substantial amounts of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing such drugs need to be aware of the potential of rapid rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to starting mass within about one and a half years.
Comparing Treatments
The analysis, which examined dozens of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with other pills.
The team note that individuals who lose weight through lifestyle changes alone usually experience a slower creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Regain
Doctors propose the mode of action of the jabs accounts for the amplified regain.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of GLP-1 levels several times higher than normal might result in the system to produce less of its own natural hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making binge eating much more probable."
A Lifelong Issue?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, considering the significant potential of weight regain, the therapy is often life-long.
This opinion is reinforced by drug manufacturers, who state that the findings "emphasize the chronic character of obesity," comparing it to managing diseases like high blood pressure.
Patient Accounts
People who have stopped the medication report a powerful return of appetite.
"It was like a trigger activating and you become extremely hungry," described a patient.
This difficulty is compounded if users have not established lasting dietary or behavioural changes during treatment.
Significant Interest
Recent estimates suggest that millions of adults in the UK have used these injections in the last 12 months, with demand remaining high.
- Use is higher among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic fix and lasting health benefits relies on integrated lifestyle changes.
